Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma

被引:0
|
作者
Munir, Muhammad Musaab [1 ]
Rashid, Zayed [1 ]
Endo, Yutaka [1 ]
Dillhoff, Mary [1 ]
Tsai, Susan [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Surg, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
关键词
LENGTH-OF-STAY; CANCER CARE; PANCREATICODUODENECTOMY;
D O I
10.1016/j.surg.2024.04.043
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Process-based quality metrics are important for improving long-term outcomes after surgical resection. We sought to develop a practical surgical quality score for patients diagnosed with pancreatic ductal adenocarcinoma undergoing curative-intent resection. Methods: Patients who underwent surgical resection for pancreatic ductal adenocarcinoma between 2010 and 2017 were identified using the National Cancer Database. Five surgical quality metrics were defined: minimally invasive approach, adequate lymphadenectomy, negative surgical margins, receipt of adjuvant therapy, and no prolonged hospitalization. Log-rank test and multivariable Cox regression analysis were used to determine the association of quality metrics with overall survival. Results: A total of 38,228 patients underwent curative-intent resection for pancreatic ductal adenocarcinoma. Median age at diagnosis was 68 years (interquartile range = 61-75), and roughly half the cohort was male (n = 19,562; 51.2%). Quality metrics were achieved on a varied basis: minimally invasive approach (n = 5,701; 14.9%), adequate lymphadenectomy (n = 27,122; 80.0%), negative surgical margin (n = 29,248; 76.5%), receipt of adjuvant therapy (n = 26,006; 68.0%), and absence of prolonged hospitalization (n = 26,470; 69.2%). An integer-based surgical quality score from 0 (no quality metrics) to 16 (all quality metrics) was calculated. Patients with higher scores had progressively better overall survival. Median overall survival differed substantially among the score categories (score = 0-4 points, 8.7 [8.0-9.6] months; 5-8 points, 17.5 [16.9-18.2] months; 9-12 points, 22.1 [21.6-22.8] months; and 13-16 points, 30.8 [30.2-31.3] months; P < .001). On multivariable analysis, risk-adjusted mortality hazards decreased in a stepwise manner with higher scores (0-4 points: reference; 5-8 points: multivariable adjusted hazard ratio = 0.60; 95% CI, 0.57-0.63; 9-12 points: adjusted hazard ratio = 0.49; 95% CI, 0.47-0.52; 13-16 points: and adjusted hazard ratio = 0.37; 95% CI, 0.34-0.40; all P < .001). Conclusion: Adherence to quality metrics may be associated with improved overall survival. Efforts aimed at increasing compliance with quality metric measures may help optimize long-term outcomes among patients undergoing surgical resection for pancreatic ductal adenocarcinoma. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 50 条
  • [41] The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
    Murakawa, Masaaki
    Aoyama, Toru
    Miyagi, Yohei
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Numata, Masakatsu
    Yamamoto, Naoto
    Tamagawa, Hiroshi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    JOURNAL OF CANCER, 2019, 10 (03): : 627 - 633
  • [42] Delay of upfront pancreatoduodenectomy in patients with ductal adenocarcinoma decreases overall survival in case of complete resection
    Joliat, G. -R.
    Labgaa, I.
    Gilgien, J.
    Halkic, N.
    Demartines, N.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 21 - 21
  • [43] Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
    Pugalenthi, Amudhan
    Protic, Mladjan
    Gonen, Mithat
    Kingham, T. Peter
    Angelica, Michael I. D'.
    Dematteo, Ronald P.
    Fong, Yuman
    Jarnagin, William R.
    Allen, Peter J.
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (02) : 188 - 193
  • [44] Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
    Korrel, M.
    Lof, S.
    van Hilst, J.
    Alseidi, A.
    Boggi, U.
    Busch, O. R.
    van Dieren, S.
    Edwin, B.
    Fuks, D.
    Hackert, T.
    Keck, T.
    Khatkov, I
    Malleo, G.
    Poves, I
    Sahakyan, M. A.
    Bassi, C.
    Abu Hilal, M.
    Besselink, M. G.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (02) : 1079 - 1087
  • [45] Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
    M. Korrel
    S. Lof
    J. van Hilst
    A. Alseidi
    U. Boggi
    O. R. Busch
    S. van Dieren
    B. Edwin
    D. Fuks
    T. Hackert
    T. Keck
    I. Khatkov
    G. Malleo
    I. Poves
    M. A. Sahakyan
    C. Bassi
    M. Abu Hilal
    M. G. Besselink
    Annals of Surgical Oncology, 2021, 28 : 1079 - 1087
  • [46] A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma
    Zhang, Li-xiang
    Chen, Lei
    Xu, A-Man
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [47] The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection (vol 27, pg 2017, 2020)
    Gruber, Elisabeth S.
    Jomrich, Gerd
    Kaider, Alexandra
    Gnant, Michael
    Sahora, Klaus
    Schindl, Martin
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 985 - 985
  • [48] Association of chemotherapy completion rates and overall survival with postoperative complications after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
    Kollbeck, Sophie L. G.
    Hansen, Carsten P.
    Dencker, Emilie E.
    Krohn, Paul S.
    Storkholm, Jan H.
    Burgdorf, Stefan K.
    Millarch, Andreas S.
    Piper, Thomas B.
    Hillingso, Jens G.
    Sillesen, Martin
    HPB, 2025, 27 (02) : 222 - 231
  • [49] Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection
    Ren, Weizheng
    Xourafas, Dimitrios
    Ashley, Stanley W.
    Clancy, Thomas E.
    JOURNAL OF SURGICAL RESEARCH, 2021, 257 : 605 - 615
  • [50] Does Preoperative Biopsy Impact Outcomes of Patients with Pancreatic Ductal Adenocarcinoma Undergoing Upfront Resection?
    Servin-Rojas, Maximiliano
    Fernandez-Del Castillo, Carlos
    Rocha-Castellanos, Dario M.
    Ferrone, Cristina R.
    Lillemoe, Keith D.
    Qadan, Motaz
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S98 - S98